US Bancorp’s Cardlytics CDLX Stock Holding History

US Bancorp’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67K	Sell	159 -110	-41%	-$1.07K	﹤0.01%	3842
2025 Q4	$3.1K	Sell	269 -71	-21%	-$1.1K	﹤0.01%	3665
2025 Q3	$8.27K	Hold	340	–	–	﹤0.01%	3377
2025 Q2	$5.6K	Buy	340 +71	+26%	+$1.23K	﹤0.01%	3608
2025 Q1	$4.9K	Sell	269 -421	-61%	-$12K	﹤0.01%	3666
2024 Q4	$25.6K	Buy	690 +169	+32%	+$6.47K	﹤0.01%	3057
2024 Q3	$16.7K	Buy	+521	New	+$28.9K	﹤0.01%	3191
2023 Q4	–	Sell	-9	Closed	-$1.45K	–	3995
2023 Q3	$1.45K	Buy	+9	New	+$1.17K	﹤0.01%	3712
2022 Q4	–	Sell	-32	Closed	-$3K	–	4154
2022 Q3	$3K	Sell	32 -8	-20%	-$1.14K	﹤0.01%	3717
2022 Q2	$9K	Buy	40 +36	+900%	+$12.1K	﹤0.01%	3385
2022 Q1	$2K	Sell	4 -2	-33%	-$1.21K	﹤0.01%	3805
2021 Q4	$4K	Sell	6 -21	-78%	-$16.1K	﹤0.01%	3698
2021 Q3	$23K	Buy	27 +3	+13%	+$3.04K	﹤0.01%	3054
2021 Q2	$31K	Buy	24 +17	+243%	+$19.2K	﹤0.01%	2901
2021 Q1	$8K	Sell	7 -2	-22%	-$2.64K	﹤0.01%	3355
2020 Q4	$13K	Buy	9 +1	+13%	+$1.07K	﹤0.01%	3078
2020 Q3	$6K	Buy	8 +6	+300%	+$4.36K	﹤0.01%	3223
2020 Q2	$1K	Buy	+2	New	+$1.16K	﹤0.01%	3580

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

US Bancorp's CDLX Position: Q1 2026 in Review

US Bancorp reduced its Cardlytics (CDLX) stake by 41% in Q1 2026, selling an estimated $1.07K and leaving 159 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

US Bancorp first reported a position in CDLX in Q2 2020 and has held it in 18 quarters since. The position peaked at $31K in Q2 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

US Bancorp held 159 shares of Cardlytics worth $1.67K as of Q1 2026.
US Bancorp sold 110 Cardlytics shares in Q1 2026, an estimated $1.07K.
Cardlytics made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3842 holding.
US Bancorp first reported a position in Cardlytics in Q2 2020 and has held it in 18 quarters since.
US Bancorp's Cardlytics position peaked at $31K in Q2 2021.
58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.